The webinar outlines how a community based rheumatology service can provide effective management of rhuematology patients, with benefits both to the patients and the use of clinical resources.
The service was initially established in 2009. Findings from the pilot study demonstrated that patients requiring disease modifying anti-rheumatic drugs (DMARDS) can easily be managed in a community setting. A community setting with provision of the specialist skills , provides patients with local more convenient care and reduced disengagement. It also optimised resource use – for example moving some of the routine follow-up activity for rheumatology patients such as drug monitoring would undercut the tariff by 30%. Patients see the most appropriate member of the healthcare team allowing more effective management of their condition and freeing up specialist rheumatologists for more acute cases.